Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Neurofibrosarcoma × CTLA-4 Antigen × Clear all

Sponsor

Conditions

Melanoma 11 Uveal Melanoma 3 Sarcoma 2 Neoplasm Metastasis 2 Lymphoma, Non-Hodgkin 2 Leukemia, Biphenotypic, Acute 2 Burkitt Lymphoma 2 Waldenstrom Macroglobulinemia 1 Uterine Cervical Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Small Cell Lung Carcinoma 1 Sezary Syndrome 1 Sarcoma, Kaposi 1 Salivary Gland Neoplasms 1 Rhabdomyosarcoma 1 Recurrent Squamous Cell Lung Carcinoma 1 Rectal Neoplasms 1 Prostatic Neoplasms 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Papillomavirus Infections 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Osteosarcoma 1 Oropharyngeal Neoplasms 1 Neuroendocrine Tumors 1 Neuroectodermal Tumors, Primitive, Peripheral 1 Neuroblastoma 1 Myelodysplastic Syndromes 1 Mycosis Fungoides 1

Interventions

Doxorubicin 4 pazopanib 3 Ifosfamide 3 Sorafenib 2 Sirolimus 2 Radiotherapy 2 Etoposide 2 thymoglobulin 1 temsirolimus 1 tazemetostat 1 romidepsin 1 pexidartinib 1 lorvotuzumab mertansine 1 liposomal doxorubicin 1 indolepropanol phosphate 1 fludarabine phosphate 1 Watchful Waiting 1 Thiotepa 1 Tacrolimus 1 Sunitinib 1 Stem Cell Transplantation 1 STA 9090 1 Razoxane 1 Radiotherapy, Intensity-Modulated 1 Radiotherapy, Conformal 1 Radiation 1 Polymerase Chain Reaction 1 Observation 1 Neoadjuvant Therapy 1 Mycophenolic Acid 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡